fenoldopam has been researched along with Myocardial Infarction in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massie, BM | 1 |
1 other study available for fenoldopam and Myocardial Infarction
| Article | Year |
|---|---|
News from the FDA Cardio-renal Advisory Committee meeting of June 26, 1997.
Topics: Antihypertensive Agents; Drug Approval; Enoxaparin; Fenoldopam; Half-Life; Humans; Myocardial Infarc | 1997 |